Opinion & features

Data show that employees would rather change jobs than travel longer, so companies with fast public transport access find it easiest to hire.

Still mired in debt, a court case sheds light on the new life of the former 'golden boy' of Israeli business, since his release from prison.

With thousands of tech employees leaving Israel, the Innovation Authority proposes measures that could reverse the trend.

Gal Rosenblum talks about his perfect job, which combines his love of sport, fashion and data analysis.

Former US National Security Agency head Michael Rogers is now a partner at VC fund Team8. He talks to "Globes" about intelligence, geopolitics, and what amazes him about Israel's tech industry.

Dr. Neal Tsur studies what makes complex systems like stock markets ripe for change, and he has put his money where his theory is.

Personal experience motivated Roy Goldenberg to become Israel director of TOM Tikkun Olam Makers. "TOM will be one of the biggest organizations to come out of Israel," he says.

Itay Raved's career drifted from law to media consulting to acting, before he finally found his niche.

The death of a cancer patient spurred Dr. Adi Zoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.